Cairo Pharmaceuticals (CPCI.CA) - Release Regarding Periodic Disclosure to Shareholders
Company Name : Cairo Pharmaceuticals
ISIN Code : EGS38391C016
Reuters Code : CPCI.CA
Content :
Release regarding periodic disclosure to shareholders in accordance with Article 29 of EGX Listing Rules.
The Release (34 KB)
ISIN Code : EGS38391C016
Reuters Code : CPCI.CA
Content :
Release regarding periodic disclosure to shareholders in accordance with Article 29 of EGX Listing Rules.
The Release (34 KB)
Comments